Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Modular Medical Inc's Competitiveness

Name: Modular Medical Inc Competitors and Peer Comparison
Creator: CSIMarket
License: https://csimarket.com/help/terms-of-use

A competitive positioning analysis and financial ratio benchmarking of Modular Medical Inc (MODD) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q1 2026

Competitors

Named by the company

Peer Group Market Share

Share of combined sales, Q1 2026

Revenue Growth Y/Y

Peers: 13.26 %

Net Margin

Peers: 10.97 %

Key Findings: Modular Medical Inc vs Its Competitors

Scale: Modular Medical Inc ranks #26 of 246 companies by market capitalization in the Medical Equipment & Supplies industry, holding 0.6% of industry market cap.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/MODD/competitors

https://api.csimarket.com/api/v1/companies/MODD/relationships

https://api.csimarket.com/api/v1/companies/MODD/similar

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Business Relationships API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AI Integration via MCP

Connect Claude, ChatGPT, or any MCP-compatible AI assistant directly to this data.

Modular Medical Inc's Competitor Quality Breadth

Group definitions: see Methodology: Performance Group Definitions.

Entity	Profitable	Expanding	Above Industry Growth	Distressed
Modular Medical Inc	-	-	-	Yes
Competitors combined (10)
High-Confidence Competitors (4)
Similar-Size Competitors (9)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

MODD Stock Performance relative to its Competitors

MODD Competitors (weighted) Percent change over the selected range

Modular Medical Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.

Competitors Combined
(4 of 9)

High-Confidence
(2 of 3)

Similar-Size
(6 of 9)

Entity	TTM Share Price Return (group: median)	vs U.S.A. 500
Modular Medical Inc	-91.50 %	Underperformed
Competitors combined (9)	40.4%	63.2%
High-Confidence Competitors (3)	40.4%	63.2%
Similar-Size Competitors (9)	40.4%	63.2%
Similar Growth & Profitability (0)	40.4%	63.2%

Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Modular Medical Inc's competitor groups requires a Commercial License.

Unlock Full Access

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

MODD Stock Performance relative to High-Confidence Competitors

MODD High-Confidence Competitors (equal-weighted, 4) Percent change over the selected range

MODD Stock Performance relative to Similar-Size Competitors

MODD Similar-Size Competitors (equal-weighted, 9) Percent change over the selected range

5 Best-Performing Tracked Competitors, Trailing 12 Months

#	Competitor	TTM Share Price Return	vs U.S.A. 500
1	Myomo Inc	282.9%	Outperformed
2	Dexcom Inc	282.9%	Outperformed
3	Medtronic Plc	282.9%	Outperformed
4	Tandem Diabetes Care Inc	282.9%	Outperformed
5	Abbott Laboratories	282.9%	Outperformed

Best-Performing Competitor Returns

TTM share price return and U.S.A. 500 outperformance for Modular Medical Inc's best-performing competitors requires a Commercial License.

Unlock Full Access

Source: CSIMarket API, trailing 12 months.

Modular Medical Inc's Comment on Competition and Industry Peers

The company projects that its Pivot pump will have a cost of goods approximately 50% lower than its nearest patch pump competitor. The Pivot pump is smaller in volume than Insulet's Omnipod and contains a 3 mL insulin reservoir, compared to the Omnipod's 2 mL reservoir. This volume difference is notable for patients requiring more than 2 mL of insulin. The company focuses on European and select international markets, emphasizing a lower-cost patch pump design and reduced training requirements. In the U.S. insulin pump market in 2026, five companies commercialize pumps, with Insulet, Tandem, and Minimed holding significant market shares of 43%, 34%, and 21%, respectively. These companies offer various insulin pump types, including disposable patch pumps and durable pumps with or without automated dosing algorithms.

Publicly Traded Peers of Modular Medical Inc

Revenue and income for trailing 12 months, in millions of $, except employees

Company	Market Cap	Revenues	Income	Employees
Modular Medical Inc	7,251.16	-	-28.03	51
Abbott Laboratories	191,605.90	46,585.00	5,425.00	115,000
Medtronic Plc	130,823.18	37,542.00	5,269.00	95,000
Dexcom Inc	30,453.73	5,104.90	992.70	11,100
Insulet Corporation	10,168.23	3,053.40	375.30	5,400
Tandem Diabetes Care Inc	1,166.98	1,037.30	-63.32	2,500
SUBTOTAL	372,312.59	94,427.63	12,054.40	231,256

5 more competitors available

Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on: November 6, 2026
Focus of this report: publicly traded companies. Ten additional tables on Modular Medical Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.

Modular Medical Inc's Competitors Named by the Company

Competitive relationships identified from Modular Medical Inc reports and corroborating sources, each with a basis and confidence.

Competitor	Basis	Confidence	Active	Sources
Tandem	Company report	85%	2022 to 2026	3
Minimed	Company report	85%	2022 to 2026	3
Insulet	Company report	85%	2022 to 2026	3
Medtronic	Company report	85%	2022 to 2026	3
Embecta Corp	Company report	85%	2022 to 2026	3
Dexcom Inc	Company report	85%	2022 to 2026	3
Vivani Medical Inc	Company report	85%	2022 to 2026	3
Semler Scientific inc	Company report	85%	2022 to 2026	3
Abbott Laboratories	Company report	85%	2022 to 2026	3
Myomo Inc	Company report	85%	2022 to 2026	3

Competitor Evidence Detail

Company report basis, confidence, active dates and source counts for Modular Medical Inc's named competitors require a Commercial License.

Unlock Full Access

Methodology: see Methodology: Peer & Competitor Identification, Sourcing.

Modular Medical Inc's Business Segment Mix vs Peers

Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).

Company	Largest Segment	2nd Segment	3rd Segment
Abbott Laboratories	Diabetes Care 16.79 %	Core Laboratory 11.05 %	Adult Nutritionals 9.21 %
Medtronic Plc	CARDIOVASCULAR 38.34 %	Neuroscience Group 28.37 %	Medical Surgical 24.10 %
Dexcom Inc	Reportable 100.00 %	-	-
Semler Scientific inc	Single reportable segment 100.00 %	-	-

Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).

Modular Medical Inc's Productivity vs Peers Comparison

Revenue and income per employee, trailing 12 months, in $; market cap in millions of $

Company	Market Cap	Revenue / Employee	Income / Employee
Modular Medical Inc	7,251	-	-549,529
Abbott Laboratories	191,606	405,087	47,174
Medtronic Plc	130,823	395,179	55,463
Dexcom Inc	30,454	459,901	89,432
Insulet Corporation	10,168	565,444	69,500
Tandem Diabetes Care Inc	1,167	414,921	-25,326
PEERS TOTAL	365,061	408,415	52,258

5 more Peers available

Modular Medical Inc's Geographic Revenue Exposure vs Peers

Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.

Company	Largest Market	2nd Market	3rd Market
Abbott Laboratories	Non-US 57.70 %	-	-
Medtronic Plc	United States 49.83 %	Total Other Countries, Excluding United States and Ireland 49.77 %	Ireland 0.40 %
Dexcom Inc	United States 72.13 %	Non-US 27.87 %	-
Insulet Corporation	United States 68.40 %	Non-US 31.62 %	-
Tandem Diabetes Care Inc	United States 67.34 %	Non-US 32.66 %	-

Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.

1 more Peers available

Modular Medical Inc's Position in Industry Market Structure

Market-capitalization share and concentration across all 218 companies in Modular Medical Inc's industry classification, broader than the peer set above. Market cap in millions of $.

Modular Medical Inc ranks #26 of 218 companies by market capitalization in its industry, holding 0.61 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 616, indicating a unconcentrated market structure (see Methodology: Market Structure & Concentration).

Rank	Company	Market Cap	Industry Share
1	Intuitive Surgical Inc	161,785	13.52 %
2	Medtronic Plc	130,823	10.94 %
3	Stryker Corp	125,786	10.51 %
4	3m Company	96,722	8.09 %
5	Boston Scientific Corporation	1,234	5.2%
6	Edwards Lifesciences Corporation	1,234	5.2%
7	Becton Dickinson And Company	1,234	5.2%
8	Alcon inc	1,234	5.2%
9	Resmed Inc	1,234	5.2%
10	Medline Inc	1,234	5.2%
26	Modular Medical Inc	7,251	0.61 %

Full Industry Market Structure

Market cap and industry share for the rest of Modular Medical Inc's industry peers requires a Commercial License.

Unlock Full Access

Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-11-06.

Modular Medical Inc's Same-Size Peers & Stock Performance

Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.

Rank	Company	Market Cap	TTM Return	3M Momentum	Beta	Sharpe (1Y)
21	The Cooper Companies Inc	12,060	-9.67 %	-18.77 %	0.68	-0.27
22	Align Technology inc	11,872	16.76 %	-9.08 %	1.37	0.57
23	Insulet Corporation	10,168	-52.72 %	1.53 %	0.79	-1.50
24	Henry Schein Inc	9,843	18.55 %	-5.28 %	0.58	0.67
25	Globus Medical Inc	1,234	12.3%	4.5%	1.10	0.80
26	Modular Medical Inc	7,251	-91.48 %	-32.62 %	1.27	-1.07
27	Teleflex Incorporated	1,234	12.3%	4.5%	1.10	0.80
28	Msa Safety Inc	1,234	12.3%	4.5%	1.10	0.80
30	Haemonetics Corporation	1,234	12.3%	4.5%	1.10	0.80
31	Lifestance Health Group Inc	1,234	12.3%	4.5%	1.10	0.80

Full Same-Size Peer Performance

Market cap, return, momentum, beta and Sharpe ratio for the rest of Modular Medical Inc's same-size peers requires a Commercial License.

Unlock Full Access

Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-11-06. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.

Modular Medical Inc's Valuation vs Competitive Position

Valuation multiples vs the Medical Equipment & Supplies industry average (342 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Medical Equipment & Supplies industry valuation benchmarks.

Metric	Company	Industry Average	Difference
P/E	-	38.2x	-
EV / EBITDA	-	18.1x	-
P/B	2,004.3x	4.6x	+1,999.8x
Return on Equity	-2.92 %	industry aggregate	-14.90 %
Return on Invested Capital	-	-6.82 % (avg)	-

Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.

Modular Medical Inc's Multi-Year Financial Trajectory

Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Revenue Growth	-	-	-	-	-	-	-	-
Operating Margin	-	-	-	-	-	-	-	-
Return on Invested Capital	-18.52 %	-44.13 %	-207.76 %	158.69 %	-69.79 %	-105.25 %	-85.24 %	-75.87 %
P/E	-	-	-	-	-	-	-	-

Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.

Modular Medical Inc's BCG Growth-Share Matrix

See Methodology: BCG Growth-Share Matrix for how relative share and growth are calculated and thresholded.

Modular Medical Inc falls in the Dog quadrant: relative market share of 0.04x vs its largest competitor, in an industry growing revenue 8.9% (median, trailing 12 months).

Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.

Modular Medical Inc's Competitive Forces (Porter's Five Forces)

Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.

Force	Assessment	Basis
Competitive Rivalry	High	Industry HHI of 616 (see Industry Market Structure & Concentration above)

Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Modular Medical Inc's dedicated Suppliers and Customers pages, not here.

Modular Medical Inc's Industry Attractiveness & Competitive Strength

See Methodology: GE/McKinsey Matrix for how the two axes are built.

High Strength

Medium Strength

Low Strength

High Attractiveness

Invest / Grow

Selective

Medium Attractiveness

Invest / Grow

Selective

Harvest

Low Attractiveness

Selective

Harvest

Harvest / Divest Modular Medical Inc

Modular Medical Inc falls in the Low attractiveness / Low strength cell: Harvest / Divest.

Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.

Modular Medical Inc's SWOT

Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.

Strengths

No rule matched.

Weaknesses

Return on equity 14.9 points below the industry aggregate.
Underperforming the U.S.A. 500 over the trailing 12 months.
Low relative market share vs the industry leader (0.04x).
Piotroski F-Score of 2 or below, the standard financial-distress signal.

Opportunities

A meaningful share of competitors (30.00 %) show financial-distress signals, a possible opening to gain share.

Threats

No rule matched.

Methodology: see Methodology: SWOT Analysis.

Modular Medical Inc's Financial Strength vs Peers Comparison

Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months

Company	Quick Ratio	Working Capital	Debt / Equity	Asset Turnover
Modular Medical Inc	3.38	3.67	-	-
Abbott Laboratories	0.42	1.50	0.44	0.48
Medtronic Plc	0.15	2.10	0.57	0.41
Dexcom Inc	0.46	1.82	0.46	0.80
Insulet Corporation	-	2.66	0.86	0.99
Tandem Diabetes Care Inc	0.43	2.94	4.40	1.02

5 more Peers available

Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.

Modular Medical Inc's Revenue and Income Growth vs Peers

Quarterly revenue and net income growth, year over year and quarter over quarter

Company	Period	Revenue Y/Y	Revenue Q/Q	Income Y/Y	Income Q/Q
Modular Medical Inc	Q2 2026	-	-	-	-
Abbott Laboratories	Q2 2026	+13.0 %	+12.8 %	-47.8 %	-13.8 %
Medtronic Plc	Q2 2026	+13.7 %	-0.5 %	+41.3 %	+17.5 %
Dexcom Inc	Q3 2026	+11.3 %	+2.8 %	-3.1 %	+9.7 %
Insulet Corporation	Q2 2026	+23.5 %	+5.3 %	+322.2 %	+4.3 %
Tandem Diabetes Care Inc	Q2 2026	+5.8 %	+3.1 %	-	-
PEERS TOTAL		+13.1 %	+6.4 %	-10.8 %	+2.6 %

5 more Peers available

Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.

Modular Medical Inc's Peers' Costs of Sales and Capital Expenditures

Context for revenue growth: peer costs and capex, year over year and quarter over quarter

Company	Period	Costs Y/Y	Costs Q/Q	Capex Y/Y	Capex Q/Q
Modular Medical Inc	Q2 2026	-	-	-26.3 %	-52.2 %
Abbott Laboratories	Q2 2026	+9.7 %	+8.9 %	-1.0 %	+24.6 %
Medtronic Plc	Q2 2026	+13.8 %	+0.5 %	-0.2 %	+1,017.8 %
Dexcom Inc	Q3 2026	+0.6 %	+0.4 %	-34.3 %	-37.5 %
Insulet Corporation	Q2 2026	+21.4 %	+2.8 %	+60.8 %	+34.2 %
Tandem Diabetes Care Inc	Q2 2026	-4.4 %	-0.2 %	-34.7 %	-35.4 %

5 more Peers available

Modular Medical Inc's Returns and Turnover vs Peers

ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover

Company	ROA	ROI	ROE	Receivables Turnover	Inventory Turnover
Modular Medical Inc	-	-	-	-	-
Abbott Laboratories	5.56%	6.45%	10.41%	5.67	2.94
Medtronic Plc	5.71%	6.46%	10.64%	5.80	2.21
Dexcom Inc	15.47%	18.92%	36.56%	4.30	2.65
Insulet Corporation	12.13%	14.30%	26.69%	6.24	1.91
Tandem Diabetes Care Inc	-	-	-	6.98	3.46

5 more Peers available

ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).

Modular Medical Inc's Valuation vs Peers

P/E, price to sales, PEG, price to cash flow and price to book

Company	P/E	Price / Sales	PEG	P/CF	Price / Book
Modular Medical Inc	-	-	-	-	673.65
Abbott Laboratories	35.35	4.11	-	-	3.70
Medtronic Plc	299.41	3.48	-	312.97	2.57
Dexcom Inc	31.26	5.97	0.35	-	12.01
Insulet Corporation	27.44	3.33	-	-	7.15
Tandem Diabetes Care Inc	-	1.13	-	-	8.95
PEERS AVERAGE	30.89	3.94		-	3.49

5 more Peers available

P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.